Literature DB >> 18297958

Adolescent substance use and abuse: recognition and management.

Kim S Griswold1, Helen Aronoff, Joan B Kernan, Linda S Kahn.   

Abstract

Substance abuse in adolescents is undertreated in the United States. Family physicians are well positioned to recognize substance use in their patients and to take steps to address the issue before use escalates. Comorbid mental disorders among adolescents with substance abuse include depression, anxiety, conduct disorder, and attention-deficit/ hyperactivity disorder. Office-, home-, and school-based drug testing is not routinely recommended. Screening tools for adolescent substance abuse include the CRAFFT questionnaire. Family therapy is crucial in the management of adolescent substance use disorders. Although family physicians may be able to treat adolescents with substance use disorders in the office setting, it is often necessary and prudent to refer patients to one or more appropriate consultants who specialize specifically in substance use disorders, psychology, or psychiatry. Treatment options include anticipatory guidance, brief therapeutic counseling, school-based drug-counseling programs, outpatient substance abuse clinics, day treatment programs, and inpatient and residential programs. Working within community and family contexts, family physicians can activate and oversee the system of professionals and treatment components necessary for optimal management of substance misuse in adolescents.

Entities:  

Mesh:

Year:  2008        PMID: 18297958

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  5 in total

1.  Opioid misuse behaviors in adolescents and young adults in a hematology/oncology setting.

Authors:  Jennifer Harman Ehrentraut; Kathleen Danielle Kern; Sarah A Long; Angel Qi An; Lane G Faughnan; Doralina L Anghelescu
Journal:  J Pediatr Psychol       Date:  2014-09-14

2.  Identifying Problematic Substance Use in a National Sample of Adolescents Using Frequency Questions.

Authors:  Laura J Chavez; Katharine A Bradley; Gwen T Lapham; Thomas M Wickizer; Deena J Chisolm
Journal:  J Am Board Fam Med       Date:  2019 Jul-Aug       Impact factor: 2.657

3.  Co-morbidity and utilization of medical services by pain patients receiving opioid medications: data from an insurance claims database.

Authors:  Theodore J Cicero; Gordon Wong; Yuhong Tian; Michael Lynskey; Alexandre Todorov; Keith Isenberg
Journal:  Pain       Date:  2009-04-10       Impact factor: 6.961

4.  Prevention of depression and anxiety in adolescents: a randomized controlled trial testing the efficacy and mechanisms of Internet-based self-help problem-solving therapy.

Authors:  Willemijn Hoek; Josien Schuurmans; Hans M Koot; Pim Cuijpers
Journal:  Trials       Date:  2009-10-12       Impact factor: 2.279

5.  Mediating and Moderating Role of Depression, Conduct Disorder or Attention-Deficit/Hyperactivity Disorder in Developing Adolescent Substance Use Disorders: A Population-Based Study.

Authors:  Kouichi Yoshimasu; William J Barbaresi; Robert C Colligan; Robert G Voigt; Amy L Weaver; Slavica K Katusic
Journal:  PLoS One       Date:  2016-06-13       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.